Company Profile

SANOFI INDIA LTD.

NSE : SANOFIBSE : 500674ISIN CODE : INE058A01010Industry : Pharmaceuticals & DrugsHouse : Sanofi India - MNC
BSE8235.35-17.3 (-0.21 % )
PREV CLOSE (Rs.) 8252.65
OPEN PRICE (Rs.) 8259.90
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 11436
TODAY'S LOW / HIGH (Rs.)8050.00 8348.00
52 WK LOW / HIGH (Rs.)5900.05 8999
NSE8267.35 10.5 (+0.13 % )
PREV CLOSE(Rs.) 8256.85
OPEN PRICE (Rs.) 8256.85
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 8267.35 (494 )
VOLUME 75318
TODAY'S LOW / HIGH(Rs.) 8022.05 8348.00
52 WK LOW / HIGH (Rs.)5900 8989

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 0.01
Dividend Yield(%) 4.24
TTM EPS (Rs.) 195.74
P/E Ratio 42.07
Book Value (Rs.) 1215.00
Face Value (Rs.) 10
MCap (Rs. in Mn) 189665.23
Price/Earning (TTM) 35.51
Price/Sales (TTM) 6.31
Price/Book (MRQ) 6.78
PAT Margin (%) 13.49
ROCE (%) 25.75
Incorporation Year : 1956

Management Info :

Aditya Narayan - Chairman Rajaram Narayanan - Managing Director

Registered Office :

Address : Sanofi House, 117-b,L&t Business Park,Saki Vihar Road, Powai,
Mumbai,
Maharashtra-400072

Phone :

Registrar's Details : Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE, MCX
NEWS More
28Oct10-28-2020$Sanofi India informs about loss of share certificate Sanofi India informs about l

Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, Sanofi India has informed that the Company has received communication from its Registrar and Share Transfer Agent on loss of share certificate(s) from the shareholder(s), Prema S Rao (Certificate No: 5497), H Sachidananda Rao (Certificate No: 53886). Further details of the same as enclosed.

The above information is a part of company’s filings submitted to BSE.

Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and..
26Oct10-26-2020$Sanofi India informs about loss of share certificate Sanofi India informs about l

Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, Sanofi India has informed that the Company has received communication from its Registrar and Share Transfer Agent on loss of share certificate(s) from the shareholders. Further details of the same as enclosed.

The above information is a part of company’s filings submitted to BSE.

Pursuant to Regulation 39(3) of SEBI (Listing Obligations and D..
22Oct10-22-2020$Sanofi India informs about loss of share certificate Sanofi India informs about l

Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, Sanofi India has informed that the company has received communication from its Registrar and Share Transfer Agent on loss of share certificate(s), details of which are enclosed.

The above information is a part of company’s filings submitted to BSE.

Pursuant to Regulation 39(3) of SEBI (Listing Obligations and D..
06Oct10-06-2020$Sanofi India informs about disclosure Sanofi India informs about d

Sanofi India has informed that pursuant to regulation 30(5) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board of Directors has authorised the Managing Director and Chief Financial Officer to determine materiality of an event or information in line with the said Regulations. The Board has also authorised the Company Secretary to disclose such information to the Stock Exchanges. The contact details of the above officials are enclosed.

The above information is a part of company’s filings submitted to BSE.

Sanofi India has informed that pursuant to regulation 30(5) of..
05Oct10-05-2020$Sanofi India informs about appointment of CFO Sanofi India informs about a
As required under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Sanofi India has informed that the Board of Directors of the Company at its meeting held on 5th October 2020 approved appointment of Vaibhav Karandikar as Chief Financial Officer (CFO) and Key Managerial Personnel with effect from 6th October 2020. A brief profile of Vaibhav Karandikar is enclosed.

The above information is a part of company’s filings submitted to BSE.

As required under Regulation 30 of the Securities and Exchange..
Financials More
Rs. in Millions
QTR Sep 20 ANNUAL 19
Net Profit13294142
Gross Profit 1859 5999
Operating Profit 20717594
Net Sales 686630706
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
Procter&Gamble Healt (BSE)
 6878.70 (8.26%)
M.Cap ( in Cr)
11418.22
Divis Lab (BSE)
 3607.60 (1.76%)
M.Cap ( in Cr)
95770.44
Ipca Laboratories (BSE)
 2196.85 (2.86%)
M.Cap ( in Cr)
27867.51
JB Chem & Pharma (BSE)
 994.25 (4.41%)
M.Cap ( in Cr)
7683.77
IOL Chem & Pharma (BSE)
 780.65 (5.02%)
M.Cap ( in Cr)
4582.85
Shareholding Pattern More
PROMOTERS 60.4 %
FI/BANKS/INSURANCE 3.21 %
MUTUAL FUNDS/UTI 12.92 %
NON-INSTITUTION 11.03 %
GOVERNMENT 0 %
FII 0 %
F & O Quotes